PPL CapEx decreased by 9.0% to $1.06B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 33.4%, from $793.00M to $1.06B. Over 4 years (FY 2021 to FY 2025), CapEx shows an upward trend with a 19.5% CAGR.
An increase often signals growth initiatives and capacity expansion, while a decrease may suggest cost-cutting or a shift toward asset-light strategies.
This metric measures the cash outflows used to acquire, upgrade, and maintain physical assets such as property, building...
Commonly compared as a percentage of revenue; capital-intensive firms like Abbott require consistent investment to remain competitive in medical technology.
capital_expenditures| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $498.00M | $491.00M | $513.00M | $427.00M | $582.00M | $506.00M | $640.00M | $499.00M | $591.00M | $651.00M | $649.00M | $596.00M | $670.00M | $679.00M | $860.00M | $793.00M | $930.00M | $1.15B | $1.16B | $1.06B |
| QoQ Change | — | -1.4% | +4.5% | -16.8% | +36.3% | -13.1% | +26.5% | -22.0% | +18.4% | +10.2% | -0.3% | -8.2% | +12.4% | +1.3% | +26.7% | -7.8% | +17.3% | +23.1% | +1.5% | -9.0% |
| YoY Change | — | — | — | — | +16.9% | +3.1% | +24.8% | +16.9% | +1.5% | +28.7% | +1.4% | +19.4% | +13.4% | +4.3% | +32.5% | +33.1% | +38.8% | +68.6% | +35.1% | +33.4% |